Sermorelin vs Testosterone Therapy: Two Different Levers for Energy and Muscle

Sermorelin and testosterone therapy are often grouped together as hormone treatments. They act on two different hormone systems. Sermorelin prompts your pituitary gland to release more of its own growth hormone. Testosterone therapy replaces testosterone directly.

If a clinician has confirmed low testosterone with symptoms and repeated morning blood tests, testosterone therapy is the treatment with FDA approval and the larger body of evidence behind it. If your testosterone is normal, or you want clinician-guided support for recovery and sleep through your growth hormone system, sermorelin is the one Harbor offers.

The honest starting point is the same for both: find out which system is actually low before choosing a lever. Energy and muscle have many causes, and neither medication fixes the wrong one.

Sermorelin: a signal to your pituitary

Sermorelin is a synthetic fragment of growth hormone-releasing hormone. It binds receptors in the pituitary and prompts the gland to make and release its own growth hormone, in pulses rather than as a constant level, because the body's own brake on growth hormone stays in place (Walker, 2006). That is the key difference from injecting growth hormone itself.

Sermorelin acts on the growth hormone system, not on testosterone production. It is prescribed as a compounded medication, which is not FDA-approved, and our explainer on what sermorelin is and how it works covers the background.

Testosterone therapy: replacing the hormone

Testosterone therapy supplies testosterone from outside the body as a gel, patch, buccal system, oral capsule or injection (FDA). It raises blood levels directly rather than asking the body to make more, which is why it can also turn down the body's own production and sperm production. That is the reason guidelines advise against starting it in men planning a pregnancy in the near term (Endocrine Society, 2018).

Testosterone products are FDA-approved for men who have low testosterone together with an associated medical condition, such as testicular failure or a pituitary problem (FDA). The Endocrine Society recommends diagnosing low testosterone only when there are symptoms and signs of deficiency and fasting morning testosterone is unequivocally low on repeated testing, then looking for the cause (Bhasin, 2018).

Labeling is changing. In February 2025 FDA asked makers to add the results of the TRAVERSE trial and a blood pressure warning to all testosterone products (FDA, 2025), and in June 2026 it requested removal of the label language saying safety and efficacy in age-related low testosterone had not been established (FDA). Diagnosis still starts with symptoms and repeat lab results.

Sermorelin programs are for adults who want a medically guided approach to recovery, body composition and sleep. A board-certified physician reviews your health history and goals before anything is prescribed, and if it is not the right fit, it is not prescribed.

A note for women

Testosterone products in the United States are approved for men (FDA). An international consensus statement found that the only evidence-based use of testosterone in women is for postmenopausal women diagnosed with hypoactive sexual desire disorder after a formal assessment (Davis, 2019), and FDA held a public meeting in September 2026 on the knowledge gaps around off-label use in menopause (FDA). Sermorelin programs are open to adults of any sex, with the same physician review.

Scroll the table sideways to see both columns →

Testosterone therapy

The Endocrine Society advises against starting testosterone in men planning fertility soon, and in men with breast or prostate cancer, an elevated hematocrit, untreated severe sleep apnea, uncontrolled heart failure, or a heart attack or stroke in the last six months. Once treatment starts, it recommends checking testosterone, hematocrit and prostate cancer risk during the first year (Bhasin, 2018).

The TRAVERSE trial found no meaningful difference in major cardiovascular events between testosterone gel and placebo, 7.0% against 7.3% (Lincoff, 2023; FDA), and FDA removed the cardiovascular-risk language from the boxed warning and added a warning about increased blood pressure (FDA, 2025).

Sermorelin

The most common effects are mild injection-site reactions such as redness, swelling or soreness, and some people notice headache, flushing or nausea early on (Harbor). Most published sermorelin research is older and focused on children with growth hormone deficiency (Prakash, 1999), so evidence in healthy adults is limited and individual responses vary.

Some clinicians prescribe sermorelin and testosterone therapy together because they act on different systems, but there is no large trial showing the combination works better than either alone. Whether it makes sense for you is a decision for the clinician who knows your full picture.

Harbor does not prescribe testosterone. If you already take it, or your primary care doctor or endocrinologist is evaluating low testosterone, tell your Harbor clinician at intake so both plans fit together, and keep your lab results in one place, as our guide to tracking blood work suggests.

The choice is rarely between a good option and a bad one. It is about matching the lever to the system that is actually underperforming.

Start with a testosterone evaluation when

• You have symptoms such as low libido, erectile problems or loss of morning erections, alongside fatigue or low mood
• You have never had a fasting morning testosterone test, or had only one
• You have a condition linked to low testosterone, such as a pituitary disorder or a history of chemotherapy
• You are a man with symptoms and want the option with FDA approval for diagnosed low testosterone

Consider sermorelin when

• Your testosterone has been checked and is normal, and you want to discuss growth hormone support with a clinician, knowing the adult evidence is limited
• You prefer working with your own growth hormone signaling rather than replacing a hormone
• You want a clinician-guided program with a simple at-home injection and ongoing check-ins
• You are comfortable with the evidence being early

Strength training and adequate protein matter for muscle whichever path you take, as Harbor's piece on why muscle mass matters explains.